Safety and Efficacy of Talactoferrin in Addition to Standard Chemotherapy in Patients With Non-small Cell Lung Cancer; FORTIS-C

Press/Media: Press / Media

PeriodOct 2 2018

Media coverage

1

Media coverage

  • TitleSafety and Efficacy of Talactoferrin in Addition to Standard Chemotherapy in Patients With Non-small Cell Lung Cancer; FORTIS-C
    Media name/outletClinical Trials.gov
    CountryUnited States
    Date10/2/18
    PersonsMissak Haigentz
View all 1
View less